Clinicians & therapists
For doctors, nurses, therapists and psychologists.
- Parkinson's8 Jan
Long-term residential exposure to chlorpyrifos is linked to more than a 2.5-fold higher risk of Parkinson's, a study suggests. The research combines human population data with lab experiments showing how the pesticide damages dopamine-producing brain cells (neurons that make the signalling chemical dopamine), providing biological evidence for the link. Around 166,000 people in the UK [...]
- Multiple sclerosis7 Jan
NICE has recommended natalizumab, sold as Tysabri and Tyruko, as an option for certain people with hard-to-control multiple sclerosis. The decision by the National Institute for Health and Care Excellence will allow NHS coverage of the drug in England, with decisions also influencing NHS coverage in other parts of the UK. The guidance specifically recommends [...]
- Tech & industry6 Jan
Researchers validated a wireless EEG method to measure neuroplasticity, offering a non-invasive way to track how the brain responds to new treatments. The approach could provide an objective readout of brain response to therapies for psychiatric and neurodegenerative conditions. Neuroplasticity is the brain’s ability to reorganise its connections after experience, injury or disease, for example [...]
- Neuropsychology5 Jan
People with high psychopathic traits face a 9.3 times higher schizophrenia risk than those with low traits, research suggests. The study also found that individuals classified as psychopathic were 2.37 times more likely to develop the condition than their non-psychopathic peers. Psychopathic traits are personality features involving shallow emotion, reduced empathy and limited remorse for [...]
- Multiple sclerosis5 Jan
An MS biomarker linked to disease progression could flag patients most likely to benefit from new drugs, researchers say. The findings were validated in mice and humans and could shape how clinical trials are run for progressive forms of the disease. The study examined “compartmentalised inflammation” (immune activity contained within the brain and spinal cord [...]
- Multiple sclerosis18 Dec
Eating more oily fish and wholegrain bread may cut the risk of multiple sclerosis, a study using UK Biobank data suggests. The findings add to evidence that diet is a modifiable factor in preventing the disease. Multiple sclerosis (MS) occurs when the immune system attacks myelin, the protective coating on nerve fibres in the brain [...]
- MND / ALS17 Dec
A new ALS blood test can identify the disease from a single blood draw with 97 per cent accuracy, researchers say. The test can also rule out people who do not have ALS, potentially ending long diagnostic delays. ALS, or amyotrophic lateral sclerosis, is a paralysing disease caused by the death of motor neurones. [...]
- Brain injury16 Dec
In a recent study, Johns Hopkins University researchers used mice to explore how the visual brain system recovers following traumatic injury. The researchers monitored connections from cells in the eye to the brain after injury. They discovered that surviving cells compensated for cell death by sprouting extra branches to make connections with more neurons in the brain. This sprouting occurred to such an extent that connections [...]
- Brain injury16 Dec
New research explains how a single mild brain injury can set off changes that increase the risk of Alzheimer’s disease. The discovery points to a possible way to prevent the disorder by repairing the brain’s drainage system after head trauma. Scientists found that traumatic brain injuries impair lymphatic vessels that connect the brain and the [...]
- Stroke12 Dec
The enzyme CEMIP is tied to myelin damage seen in multiple sclerosis, stroke and Alzheimer's, new research has revealed, pointing to a new target for brain repair. Researchers aim to develop ways to target the enzyme to heal or slow disease. The study, from Oregon Health & Science University, found that cell migration inducing and [...]

















